keyword
https://read.qxmd.com/read/39355130/radiomics-based-machine-learning-models-for-differentiating-pathological-subtypes-in-cervical-cancer-a-multicenter-study
#21
JOURNAL ARTICLE
Huiling Liu, Mi Lao, Yalin Zhang, Cheng Chang, Yong Yin, Ruozheng Wang
PURPOSE: This study was designed to determine the diagnostic performance of fluorine-18-fluorodeoxyglucose (18 F-FDG) positron emission tomography (PET)/computed tomography (CT) radiomics-based machine learning (ML) in the classification of cervical adenocarcinoma (AC) and squamous cell carcinoma (SCC). METHODS: Pretreatment 18 F-FDG PET/CT data were retrospectively collected from patients who were diagnosed with locally advanced cervical cancer at two centers. Radiomics features were extracted and selected by the Pearson correlation coefficient and least absolute shrinkage and selection operator regression analysis...
2024: Frontiers in Oncology
https://read.qxmd.com/read/39354775/an-updated-review-summarizing-the-pharmaceutical-efficacy-of-genistein-and-its-nanoformulations-in-ovarian-carcinoma
#22
JOURNAL ARTICLE
Pratibha Pandey, Seema Ramniwas, Shivam Pandey, Meenakshi Verma, Rahul Kumar, Sorabh Lakhanpal, Fahad Khan, Mohd Asif Shah
Implementing lifestyle interventions as a primary prevention strategy is a cost-effective approach to reducing the occurrence of cancer, which is a significant contributor to illness and death globally. Recent advanced studies have uncovered the crucial role of nutrients in safeguarding women's health and preventing disorders. Genistein is an abundant isoflavonoid found in soybeans. Genistein functions as a chemotherapeutic drug against various forms of cancer, primarily by modifying apoptosis, the cell cycle, and angiogenesis and suppressing metastasis...
October 1, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/39354488/cervical-cancer-screening-delay-and-associated-factors-among-women-with-hiv-in-lesotho-a-mixed-methods-study
#23
JOURNAL ARTICLE
Michelle T Harder, Moliehi Mokete, Frédérique Chammartin, Malebanye Lerotholi, Lipontso Motaboli, Mathebe Kopo, Mpho Kao, Moleboheng Mokebe, Ntoiseng Chejane, Palesa Mahlatsi, Morongoe Nyakane, Tapiwa Tarumbiswa, Niklaus D Labhardt, Nadine Tschumi, Jennifer M Belus
BACKGROUND: Cervical cancer is the fourth most common cancer in women worldwide, and women with human immunodeficiency virus (HIV) are particularly at risk of developing it. Regular screening effectively prevents morbidity and mortality. This mixed-methods study quantitatively assessed cervical cancer screening uptake and qualitatively explored the process of undergoing cervical cancer screening to understand possible reasons for delayed screening among women with HIV in Lesotho. METHODS: Between October 2020 and March 2022, the Viral load Triggered ART care in Lesotho (VITAL) trial enrolled women aged 18 years and older with HIV who were taking antiretroviral therapy (ART)...
October 1, 2024: BMC Women's Health
https://read.qxmd.com/read/39354287/dissecting-the-single-cell-diversity-and-heterogeneity-underlying-cervical-precancerous-lesions-and-cancer-tissues
#24
JOURNAL ARTICLE
Yanling Han, Lu Shi, Nan Jiang, Jiamin Huang, Xiuzhi Jia, Bo Zhu
The underlying cellular diversity and heterogeneity from cervix precancerous lesions to cervical squamous cell carcinoma (CSCC) is investigated. Four single-cell datasets including normal tissues, normal adjacent tissues, precancerous lesions, and cervical tumors were integrated to perform disease stage analysis. Single-cell compositional data analysis (scCODA) was utilized to reveal the compositional changes of each cell type. Differentially expressed genes (DEGs) among cell types were annotated using BioCarta...
October 1, 2024: Reproductive Sciences
https://read.qxmd.com/read/39353536/an-overview-of-lncrna-neat1-contribution-in-the-pathogenesis-of-female-cancers-from-diagnosis-to-therapy-resistance
#25
REVIEW
Sulieman Ibraheem Shelash Al-Hawary, Saade Abdalkareem Jasim, Farag M A Altalbawy, Pooja Bansal, Harpreet Kaur, Ahmed Hjazi, Jaafaru Sani Mohammed, Mahamedha Deorari, Salim B Alsaadi, Ahmed Hussein Zwamel
Despite the ongoing progress in detecting and treating cancer, there is still a need for extensive research into the molecular mechanisms involved in the emergence, progression, and resistance to recurrence of female reproductive tissue-specific cancers such as ovarian, breast, cervical, and endometrial cancers. The nuclear paraspeckle assembly transcript 1 (NEAT1) is a long non-coding RNA (lncRNA) that exhibits increased expression in female tumors. Moreover, elevated levels of NEAT1 have been associated with poorer survival outcomes in cancer patients...
September 29, 2024: Gene
https://read.qxmd.com/read/39353396/systemic-administration-of-a-potent-mouse-monoclonal-antibody-provides-multisite-protection-against-hpv16-infection
#26
JOURNAL ARTICLE
Bilian Huang, Doudou Zhang, Hongyun Wang, Siyu Li, Jianjun Guo, Shengwei Cui, Xiaoping Chen, Ying Hong, Zhiwei Wu
Although preventive vaccines for Human Papillomaviruses (HPV) are available, a definitive cure for the viral infection itself is currently lacking. There is a sizable population that remains inaccessible to HPV vaccination due to reasons such as high costs or lack of availability of the vaccines. Therefore, there remains a significant population susceptible to HPV infection. Persistent multisite infections with high-risk HPV types can cause cancer at several different anatomic sites.Especially HPV16 is a key etiologic factor for cervical, other ano-genital and oropharyngeal cancers...
September 30, 2024: International Immunopharmacology
https://read.qxmd.com/read/39353319/research-advances-in-signaling-pathways-related-to-the-malignant-progression-of-hsil-to-invasive-cervical-cancer-a-review
#27
REVIEW
Huifang Wang, Chang Liu, Keer Jin, Xiang Li, Jiaxin Zheng, Danbo Wang
The progression of high-grade squamous intraepithelial lesion (HSIL) to invasive cervical cancer (ICC) is a complex process involving persistent human papillomavirus (HPV) infection and changes in signal transduction regulation, energy and material metabolism, cell proliferation, autoimmune, and other biological process in vaginal microenvironment and immune microenviroment. Signaling pathways are a series of interacting molecules in cells that regulate various physiological functions of cells, such as growth, differentiation, metabolism, and death...
September 30, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/39353164/sexual-health-and-quality-of-life-in-patients-with-low-risk-early-stage-cervical-cancer-results-from-gcig-cctg-cx-5-shape-trial-comparing-simple-versus-radical-hysterectomy
#28
JOURNAL ARTICLE
Sarah E Ferguson, Lori A Brotto, Janice Kwon, Vanessa Samouelian, Gwenael Ferron, Amandine Maulard, Cor de Kroon, Willemien Van Driel, John Tidy, Karin Williamson, Sven Mahner, Stefan Kommoss, Frederic Goffin, Karl Tamussino, Brynhildur Eyjolfsdottir, Jae-Weon Kim, Noreen Gleeson, Dongsheng Tu, Lois Shepherd, Marie Plante
PURPOSE: Simple hysterectomy and pelvic node assessment (SHAPE) is a phase III randomized trial (ClinicalTrials.gov identifier: NCT01658930) reporting noninferiority of simple compared with radical hysterectomy for oncologic outcomes in low-risk cervical cancer. This study presents secondary outcomes of sexual health and quality of life (QOL) of the SHAPE trial. METHODS: Participants were randomly assigned to receive either radical or simple hysterectomy. Sexual health was assessed up to 36 months postoperatively using the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Revised and QOL using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 and Cervical Cancer-Specific Module (QLQ-CX24) questionnaires...
October 1, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/39352425/unraveling-the-role-of-epha2-in-regulating-migration-and-immunomodulation-processes-in-cervical-cancer-exploring-the-synergic-effect-of-17%C3%AE-estradiol-on-cancer-progression
#29
JOURNAL ARTICLE
P P Mubthasima, Anbarasu Kannan
Cervical cancer remained among the most prevalent cancers in women. Erythropoietin-producing hepatocellular A2 (EPHA2) is overexpressed in many cancers, including cervical cancer, and the mechanism by which it regulates cervical cancer progression is not yet fully understood. Exosomes are extracellular vesicles that carry information in the form of biomolecules, deliver it to the recipient cell, and play a vital role in cellular communication. 17β-Estradiol is the natural female steroid hormone with the greatest estrogenic activity, and it induces cell death in cancer...
October 1, 2024: Medical Oncology
https://read.qxmd.com/read/39352309/methylation-gene-expression-and-risk-genotypes-at-the-tert-clptm1l-locus-in-cervical-cancer
#30
JOURNAL ARTICLE
Dhanya Ramachandran, Qianqian Mao, Dandan Liao, Maud Kamal, Peter Schürmann, Rieke Eisenblätter, Robert Geffers, Balazs Balint, Lolita Lecompte, Nicolas Servant, Linda Larbi Chérif, Constance Lamy, Sylvain Baulande, Patricia Legoix, Christophe Le Tourneau, Aurélien Latouche, Peter Hillemanns, Suzy Scholl, Thilo Dörk
The reverse transcriptase subunit of telomerase, TERT, is frequently activated in high-grade dysplasia and invasive cancers of the uterine cervix. Telomerase activation through hypomethylation of the TERT promoter holds promise as a biomarker for cervical cancer progression, however, specific CpG sites involved in cervical cancer risk remain to be fully defined. A recent genome-wide association study on cervical cancer identified genetic polymorphisms at 5p13.33 (close to TERT-CLPTM1L) but the underlying mechanisms are undetermined...
October 1, 2024: Molecular Carcinogenesis
https://read.qxmd.com/read/39352127/the-prognosis-of-patients-with-locally-advanced-cervical-cancer-undergoing-surgical-versus-non-surgical-treatment-a-retrospective-cohort-study-based-on-seer-database-and-a-single-center-data
#31
JOURNAL ARTICLE
Xinyan Gao, Yan Kong, Ying Ning, Tian Tian, Xiaojing Gai, Ke Lei, Zuimei Cui
The aim of this study was to investigate the impact of surgical treatment on the survival prognosis of patients with locally advanced cervical cancer (LACC) and to identify factors that may influence the efficacy of surgery. Data from the SEER database (2000-2020) and a hospital (2013-2023) were collected for this investigation. Utilizing multivariable Cox regression analysis, Kaplan-Meier survival analysis, and log-rank tests, we assessed the effects of surgical intervention on overall survival (OS) and disease-specific survival (DSS) in LACC patients...
October 1, 2024: International Journal of Surgery
https://read.qxmd.com/read/39352091/comparison-of-cervical-cancer-screening-models-based-on-pap-and-hpv-tests-in-tbilisi-georgia
#32
COMPARATIVE STUDY
Eter Kiguradze, Tamar Skhirtladze, Nikoloz Chkhartishvili, Tamuna Gogoladze, Nino Chikhladze, Tamar Alibegashvili
OBJECTIVE: The objective of this study was to evaluate the effectiveness of human papillomavirus HPV test with HPV16/18 genotyping and liquid-based cytology (LBC) triage as a primary screening method for cervical cancer compared to conventional Pap test in women undergoing routine cervical cancer screening in Tbilisi. METHODS: Cross-sectional, prospective study was conducted, where 1,000 enrolled women aged 30-60 years during one visit underwent conventional Pap smear and Hr-HPV testing (Roche Cobas system)...
September 2024: Central European Journal of Public Health
https://read.qxmd.com/read/39351768/prognostic-value-of-imp3-expression-in-squamous-cervical-cancer
#33
JOURNAL ARTICLE
Tanja Krešić, Marko Klarić, Senija Eminović, Anita Kolobarić, Ana Dugandžić Šimić, Ana Bošković
Cervical cancer remains one of the leading causes of death from malignant diseases in women worldwide. Primary and secondary prevention have led to better outcomes in developed countries, whereas in developing countries, cervical cancer continues to be responsible for an unjustifiably high number of fatalities. The discovery of new tumor biomarkers can lead to earlier diagnosis, better therapeutic decisions, and improved treatment methods. IMP3 is a protein responsible for invasiveness and other aggressive characteristics of tumor processes...
September 20, 2024: Applied Immunohistochemistry & Molecular Morphology: AIMM
https://read.qxmd.com/read/39351618/weekly-image-guidance-in-patients-with-cervical-cancer-treated-with-intensity-modulated-radiation-therapy-results-of-a-large-cohort-study
#34
JOURNAL ARTICLE
Zheng Zeng, Weiping Wang, Junfang Yan, Dingchao Liu, Fuquan Zhang, Ke Hu
BACKGROUND: Image guidance is recommended for patients undergoing intensity-modulated radiation therapy (IMRT) for cervical cancer. In this study, we evaluated the feasibility of a weekly image guidance pattern and analyzed the long-term outcomes in a large cohort of patients. METHODS: The study enrolled patients with Stage IB-IVA cervical cancer who received definitive radiotherapy or concurrent chemoradiotherapy. IMRT was delivered at a dose of 50.4 Gy in 28 fractions, with weekly cone-beam computed tomography (CBCT)...
September 2024: Cancer Medicine
https://read.qxmd.com/read/39351438/evaluation-of-her2-immunohistochemistry-expression-in-non-standard-solid-tumors-from-a-single-institution-prospective-cohort
#35
JOURNAL ARTICLE
Saurav Verma, Amanda Chapman, Lee-Anne Pickard, Danielle Porplycia, Haley McConkey, Patricia Jarosz, James Sinfield, Carolyn Lauzon-Young, Matthew J Cecchini, Christopher Howlett, Natalie Grindrod, Bekim Sadikovic, Stephen A Welch, Daniel Breadner
AIM: Human epidermal growth factor receptor-2 (HER2) is a well-established prognostic and predictive biomarker. It is an FDA-approved therapeutic target for HER2 positive breast, gastroesophageal, and more recently, lung and colon cancers. It is an emerging biomarker in biliary tract, bladder, cervical, endometrial, ovarian, and pancreatic cancers. The emergence of new indications warrants further characterization of HER2 expression in diverse cancer populations. This study investigated HER2 expression in solid tumour samples and the feasibility of obtaining these results...
2024: Exploration of targeted anti-tumor therapy
https://read.qxmd.com/read/39351402/implementation-of-the-cervical-cancer-prevention-policy-in-one-of-the-regions-of-lithuania
#36
JOURNAL ARTICLE
Gerda Bukauskaitė Žiūkienė, Alina Liepinaitienė
INTRODUCTION: Although the Lithuanian government increases funding for the cervical cancer prevention program every year, the incidence and mortality rates of cervical cancer are among the highest in Europe. In order to improve the prevention policy regarding cervical cancer, it is necessary to investigate the implementation of the cervical cancer prevention policy in one of the regions in Lithuania. METHODS: A quantitative survey method using a questionnaire, was applied in one of the regions of Lithuania...
2024: European journal of midwifery
https://read.qxmd.com/read/39351348/exploring-the-impact-of-network-depth-on-3d-u-net-based-dose-prediction-for-cervical-cancer-radiotherapy
#37
JOURNAL ARTICLE
Mingqing Wang, Yuxi Pan, Xile Zhang, Ruijie Yang
PURPOSE: The 3D U-Net deep neural network structure is widely employed for dose prediction in radiotherapy. However, the attention to the network depth and its impact on the accuracy and robustness of dose prediction remains inadequate. METHODS: 92 cervical cancer patients who underwent Volumetric Modulated Arc Therapy (VMAT) are geometrically augmented to investigate the effects of network depth on dose prediction by training and testing three different 3D U-Net structures with depths of 3, 4, and 5...
2024: Frontiers in Oncology
https://read.qxmd.com/read/39351236/efficacy-and-safety-of-chemoradiotherapy-plus-immune-checkpoint-inhibitors-for-the-treatment-of-locally-advanced-cervical-cancer-a-systematic-review-and-meta-analysis
#38
JOURNAL ARTICLE
Zhihong Zhao, Jian Ruan, Minjie Fang, Jingwen Liu, Guixiang Liao
BACKGROUND: Radiotherapy plus concurrent chemotherapy is a standard method for treating locally advanced cervical cancer (LACC). Immune checkpoint inhibitors (ICIs) are widely applied in the treatment of recurrent cervical cancer, metastatic cervical cancer or LACC. The efficacy and safety of radiotherapy plus immunotherapy for LACC require further investigation. The objective of this review and meta-analysis was to analyze the efficacy and safety of concurrent chemoradiotherapy (CCRT) combined with ICIs for treating LACC on the basis of the results of randomized controlled trials (RCTs)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/39351073/genetic-dysregulation-of-ep300-in-cancers-in-light-of-cancer-epigenome-control%C3%A2-targeting-of-p300-proficient-and-deficient-cancers
#39
REVIEW
Karolina Gronkowska, Agnieszka Robaszkiewicz
Some cancer types including bladder, cervical, and uterine cancers are characterized by frequent mutations in EP300 that encode histone acetyltransferase p300. This enzyme can act both as a tumor suppressor and oncogene. In this review, we describe the role of p300 in cancer initiation and progression regarding EP300 aberrations that have been identified in TGCA Pan-Cancer Atlas studies and we also discuss possible anticancer strategies that target EP300 mutated cancers. Copy number alterations, truncating mutations, and abnormal EP300 transcriptions that affect p300 abundance and activity are associated with several pathological features such as tumor grading, metastases, and patient survival...
December 19, 2024: Mol Ther Oncol
https://read.qxmd.com/read/39350418/an-overview-of-the-anticancer-potential-of-silver-nanostructures-against-cervical-cancer
#40
JOURNAL ARTICLE
Adarsh Kumar, Dhruv Varshney, Shivam Kumar, Sarmistha Saha
Women are impacted by the extremely common cancer known as cervical cancer worldwide. Although preventive vaccines for cervical cancer are successful, treatment of cervical cancer is far less satisfactory because of multidrug resistance and side effects. There is an increasing need for alternative treatment modalities due to the rather aggressive and non-specific nature of conventional chemotherapeutics. With the advent of new technologies, scientists are working harder to create novel drug delivery strategies for chemotherapy of cervical cancer...
September 27, 2024: Pharmaceutical Nanotechnology
keyword
keyword
2350
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.